William Jl Rieflin is of RAPT Therapeutics, Inc.. Currently has a direct ownership of 18,000 shares of RAPT, which is worth approximately $19,440. The most recent transaction as insider was on Nov 19, 2020, when has been sold 10,000 shares (Common Stock) at a price of $16.22 per share, resulting in proceeds of $162,200. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 18K
0% 3M change
0% 12M change
Total Value Held $19,440

WILLIAM JL RIEFLIN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 19 2020
BUY
Open market or private purchase
$162,200 $16.22 p/Share
10,000 Added 35.71%
18,000 Common Stock

Also insider at

NGM
NGM BIOPHARMACEUTICALS INC Healthcare
LYEL
Lyell Immunopharma, Inc. Healthcare
WJR

William Jl Rieflin

South San Francisco, CA

Track Institutional and Insider Activities on RAPT

Follow RAPT Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RAPT shares.

Notify only if

Insider Trading

Get notified when an Rapt Therapeutics, Inc. insider buys or sells RAPT shares.

Notify only if

News

Receive news related to RAPT Therapeutics, Inc.

Track Activities on RAPT